[ Price : $8.95]
Three stakeholders express support for FDAs LEADER 3D rare disease educational materials and suggest ways to improve them.[ Price : $8.95]
FDAs just-released proposed fiscal year 2027 budget seeks a 3.3% increase or about $200 million to fund the agencys operations.[ Price : $8.95]
FDAs updated guidance on how patient preference information can be incorporated into regulatory decision-making for medical device...[ Price : $8.95]
Amgen reports positive topline results from a Phase 3 trial evaluating a subcutaneous version of its thyroid eye disease drug Tepe...[ Price : $8.95]
ImmunityBio says it has responded to FDAs recent Warning Letter on the companys alleged misleading promotional claims about its ca...[ Price : $8.95]
FDA clears an Anumana 510(k) for an artificial intelligencebased tool designed to detect early signs of pulmonary hypertension.[ Price : $8.95]
FDA posts a Form 483 that identifies deficiencies in quality system procedures at a manufacturing facility operated by CSL Behring...[ Price : $8.95]
FDAs new draft guidance outlining expectations for how drug manufacturers should respond to Form FDA 483 observations following in...